Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Lucy A. Godley, Timothy S. Olson
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Outcomes of germline testing for children with hematologic malignancies undergoing hematopoietic cell transplantation
2026
Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromes
10.3324/haematol.2019.237693 · 2021
The clinical and functional effects of TERT variants in myelodysplastic syndrome
10.1182/blood.2021011075 · 2021
Management of patients with germline predisposition to haematological malignancies considered for allogeneic blood and marrow transplantation: best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar, NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group and the British Society of Blood and Marrow Transplantation and cellular therapy (BSBMTCT)
10.1111/bjh.18682 · 2023
Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT
10.1016/s2352-3026(23)00265-x · 2023
Donor-derived malignancy and transplantation morbidity: risks of patient and donor genetics in allogeneic hematopoietic stem cell transplantation
2024
Germline predispositions to myeloid malignancies: across the lifespan
10.1053/j.seminhematol.2025.08.002 · 2025
Insights into germline predisposition to pediatric lymphoid malignancies
10.1038/s41375-025-02750-z · 2025
Risk of cancer in heterozygous relatives of patients with Fanconi anemia
10.1016/j.gim.2021.08.013 · 2022
Genome-first determination of the prevalence and penetrance of eight germline myeloid malignancy predisposition genes: a study of two population-based cohorts
10.1038/s41375-024-02436-y · 2025
No additional external references are available.